Complete Filing Data
Sparx Holdings Group, Inc. reported Proceeds From Contributed Capital of $27.3 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sparx Holdings Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Net Income Loss | -$47.7K | -$5.7K | -$4.7K |
| Operating Expenses | $47.7K | $5.7K | $4.7K |
| General And Administrative Expense | $46.8K | $5.7K | $4.7K |
| Other Research And Development Expense | $842.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$38.0K | -$13.9K | -$2.1K | -$14.8K | -$950.00 | -$1.9K | -$782.00 |
| Operating Expenses | $38.0K | $13.9K | $2.1K | $14.8K | $950.00 | $1.9K | $782.00 |
| General And Administrative Expense | $36.9K | $13.9K | $2.1K | $14.8K | $950.00 | $1.9K | $782.00 |
| Other Research And Development Expense | $1.1K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Stockholders Equity * | $99.6K | -$3.8K | |
| Retained Earnings Accumulated Deficit | -$10.5K | -$4.7K | |
| Common Stock Value | $17.9K | ||
| Liabilities | $3.8K | ||
| Accrued Liabilities Current | $3.8K | ||
| Liabilities And Stockholders Equity | |||
| Cash And Cash Equivalents At Carrying Value | |||
| Assets | |||
| Cashsalesofstockperiod | $100.0K | ||
| Cash And Cash Equivalents Period Increase Decrease | $100.2K | ||
| Accrued Liabilities And Other Liabilities | |||
| Cashcontributionsrelatedparty | $4.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $107.2K | $99.6K | -$350.00 | -$350.00 | -$500.00 | |||
| Retained Earnings Accumulated Deficit | $107.2K | $99.6K | -$41.2K | -$27.3K | -$25.2K | -$8.3K | -$7.3K | -$5.5K |
| Common Stock Value | $28.5K | $28.4K | $27.9K | $27.9K | $27.9K | $17.9K | $17.9K | $17.9K |
| Liabilities | $600.00 | $350.00 | $350.00 | $500.00 | ||||
| Accrued Liabilities Current | $350.00 | $350.00 | $500.00 | |||||
| Liabilities And Stockholders Equity | $107.2K | $100.2K | ||||||
| Cash And Cash Equivalents At Carrying Value | $107.2K | $100.2K | ||||||
| Assets | $107.2K | $100.2K | ||||||
| Cashsalesofstockperiod | $30.5K | |||||||
| Cash And Cash Equivalents Period Increase Decrease | $6.9K | |||||||
| Accrued Liabilities And Other Liabilities | $600.00 | |||||||
| Cashcontributionsrelatedparty |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Proceeds From Contributed Capital | $27.3K | $9.5K | $960.00 |
| Increase Decrease In Accrued Liabilities | $600.00 | -$3.8K | $3.8K |
| Net Cash Provided By Used In Operating Activities | -$3.8K | ||
| Net Cash Provided By Used In Financing Activities | $104.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|
| Proceeds From Contributed Capital | $15.1K | $7.9K | $2.1K | $4.8K | $950.00 | $2.0K | $4.0K |
| Increase Decrease In Accrued Liabilities | -$600.00 | -$3.3K | |||||
| Net Cash Provided By Used In Operating Activities | -$23.6K | ||||||
| Net Cash Provided By Used In Financing Activities | $30.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Common Stock Shares Issued | 0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 257.2M | 178.8M | |
| Earnings Per Share Basic And Diluted | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 500.0M | 500.0M | |
| Shares Issued | 283.8M | 178.8M | |
| Preferred Stock Shares Authorized | 5.0K | 5.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | |
| Common Stock Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 285.4M | 283.8M | 278.8M | 278.8M | 278.8M | 178.8M | 178.8M | 178.8M | 178.8M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 285.5M | 278.8M | 278.8M | 196.7M | 178.8M | 178.8M | 178.8M | |||
| Earnings Per Share Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 500.0M | 0.00 | 0.00 | 0.00 | 200.0M | 200.0M | 200.0M | 200.0M | ||
| Shares Issued | 278.8M | 278.8M | 278.8M | 178.8M | 178.8M | 178.8M | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 178.8M | 178.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Additional Paid In Capital | -$7.4K | $960.00 | |
| Stockbalance | |||
| Sharesissuedascompensation | |||
| Sharebasedcompperiod | |||
| Sharebasedcomp | $16.0K | ||
| Sale Of Stock Consideration Received Per Transaction | $100.0K | ||
| Stock Issued During Period Shares Conversion Of Units | |||
| Sharesissuedcompensationperiod | |||
| Sharesissuedcompensation | 16.0K | ||
| Sharesissuedascompperiod | |||
| Contributionstocapital | $4.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $174.8K | $129.4K | -$13.2K | -$595.00 | -$2.6K | -$9.9K | -$10.9K | -$12.9K |
| Stockbalance | $178.8M | $178.8M | $178.8M | |||||
| Sharesissuedascompensation | 10.0K | |||||||
| Sharebasedcompperiod | $10.0K | |||||||
| Sharebasedcomp | $10.0K | |||||||
| Sale Of Stock Consideration Received Per Transaction | $30.5K | |||||||
| Stock Issued During Period Shares Conversion Of Units | 178.8M | |||||||
| Sharesissuedcompensationperiod | 10.0K | |||||||
| Sharesissuedcompensation | ||||||||
| Sharesissuedascompperiod | 6.0K | |||||||
| Contributionstocapital |
Most recent annual filing with the SEC: September 8, 2023
Data sourced from SEC EDGAR public filings as of August 4, 2026.